| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer
|
Hara, Hidenori
|
|
2001
|
34 |
2 |
p. 219-226
8 p.
|
artikel
|
| 2 |
Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II
|
Jin, Mulan
|
|
2001
|
34 |
2 |
p. 207-218
12 p.
|
artikel
|
| 3 |
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin
|
Jiménez-Orozco, Fausto Alejandro
|
|
2001
|
34 |
2 |
p. 185-194
10 p.
|
artikel
|
| 4 |
Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre
|
Bozcuk, Hakan
|
|
2001
|
34 |
2 |
p. 243-252
10 p.
|
artikel
|
| 5 |
Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer
|
Suzuki, Yoshihiro
|
|
2001
|
34 |
2 |
p. 195-205
11 p.
|
artikel
|
| 6 |
Fluorescence bronchoscopy for early detection of lung cancer
|
Sutedja, Tom G.
|
|
2001
|
34 |
2 |
p. 157-168
12 p.
|
artikel
|
| 7 |
Gemcitabine and small cell lung cancer
|
Scarpati, Michele Della Vittoria
|
|
2001
|
34 |
2 |
p. 313-314
2 p.
|
artikel
|
| 8 |
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study—Cancer and Leukemia Group B 9631
|
Kosty, Michael P
|
|
2001
|
34 |
2 |
p. 289-295
7 p.
|
artikel
|
| 9 |
High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer
|
Anacak, Yavuz
|
|
2001
|
34 |
2 |
p. 253-259
7 p.
|
artikel
|
| 10 |
High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression
|
Ushijima, Chie
|
|
2001
|
34 |
2 |
p. 233-241
9 p.
|
artikel
|
| 11 |
Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia
|
Potti, Anil
|
|
2001
|
34 |
2 |
p. 227-232
6 p.
|
artikel
|
| 12 |
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer
|
Novello, Silvia
|
|
2001
|
34 |
2 |
p. 261-269
9 p.
|
artikel
|
| 13 |
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer
|
Clark, Joseph I
|
|
2001
|
34 |
2 |
p. 271-277
7 p.
|
artikel
|
| 14 |
Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population
|
Lewis, Sarah J
|
|
2001
|
34 |
2 |
p. 177-183
7 p.
|
artikel
|
| 15 |
Practical approach to patients presenting with multiple synchronous suspect lung lesions
|
Vansteenkiste, Johan F.
|
|
2001
|
34 |
2 |
p. 169-175
7 p.
|
artikel
|
| 16 |
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
|
Ceresoli, Giovanni Luca
|
|
2001
|
34 |
2 |
p. 279-287
9 p.
|
artikel
|
| 17 |
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer
|
Langer, Corey J
|
|
2001
|
34 |
2 |
p. 297-303
7 p.
|
artikel
|
| 18 |
Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer
|
Montalar, J
|
|
2001
|
34 |
2 |
p. 305-311
7 p.
|
artikel
|
Tijdschrift beschrijving